Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

49.8K
Overview
49.8K
Development of Immunocompetence01:22

Development of Immunocompetence

601
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
601
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

718
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
718
Active versus Passive Immunity01:31

Active versus Passive Immunity

9.4K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
9.4K
Rh Blood Group01:19

Rh Blood Group

2.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.4K
Cancer Vaccines01:30

Cancer Vaccines

764
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
764

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted Oxygen for Initial Resuscitation of Preterm Infants: The TORPIDO 30/60 Randomized Clinical Trial.

JAMA·2025
Same author

E-Prem checklist-driven strategy to improve outcomes in extremely preterm and low birth weight infants: a quasi-experimental study at a national referral hospital in Indonesia.

BMJ open·2025
Same author

Reducing device-related pressure injuries in high-risk neonates receiving nasal continuous positive airway pressure: a quality improvement study.

Archives of disease in childhood. Fetal and neonatal edition·2025
Same author

Voluntary Neonatal Medication Incident Reporting-A Single Centre Retrospective Analysis.

Healthcare (Basel, Switzerland)·2024
Same author

Diagnosis, management and long term cardiovascular outcomes of phenotypic profiles in pulmonary hypertension associated with congenital diaphragmatic hernia.

Frontiers in pediatrics·2024
Same author

Minor painful procedures in extremely preterm infants admitted to a tertiary neonatal intensive care unit: Opportunities to improve pain mitigation.

Journal of paediatrics and child health·2023
Same journal

Occupational exposures and maternal mental health across the perinatal period: a systematic review.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Essential tips on sample size calculation and biostatistics.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Non-immune causes of fetal anemia.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

A risk-based classification of late-onset fetal growth disorders according to intrapartum fetal compromise.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

The Cardiac-Fetal-Placental Unit: links between umbilical venous flow and maternal hemodynamics in fetal growth restriction.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Psychosocial interventions for women who are pregnant following a previous reproductive loss: A scoping review.

Best practice & research. Clinical obstetrics & gynaecology·2026
See all related articles

Related Experiment Video

Updated: Dec 3, 2025

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

3.9K

Vaccinations in the newborn.

Tejasvi Chaudhari1

  • 1Australian National University Medical School, Canberra, Australia.

Best Practice & Research. Clinical Obstetrics & Gynaecology
|November 1, 2020
PubMed
Summary
This summary is machine-generated.

Neonatal immunization protects vulnerable infants from serious infections. Despite challenges like immature immune systems, vaccines like Hepatitis B, BCG, and OPV are safe and effective at birth.

Keywords:
AdjuvantImmune systemImmunisationNeonatePretermVaccine

More Related Videos

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

60.4K
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

20.1K

Related Experiment Videos

Last Updated: Dec 3, 2025

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

3.9K
Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

60.4K
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

20.1K

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Neonates possess immature immune systems, increasing susceptibility to severe infections.
  • Challenges in neonatal vaccination include maternal antibody interference and a Th2-skewed immune response.
  • Despite these hurdles, some vaccines demonstrate efficacy in newborns.

Purpose of the Study:

  • To review current neonatal vaccination practices, including those for high-risk preterm infants.
  • To explore novel strategies for improving vaccine responses in neonates.
  • To highlight the importance of early immunization in this vulnerable population.

Main Methods:

  • Literature review of current neonatal vaccines and their efficacy.
  • Analysis of immunological challenges in the neonatal period.
  • Exploration of emerging vaccine technologies and approaches.

Main Results:

  • Hepatitis B, BCG, and OPV are currently administered to neonates, proving safe and effective.
  • Certain antigen-adjuvant combinations can induce protective immune responses in newborns.
  • Ongoing research aims to overcome immunological barriers to enhance neonatal vaccine efficacy.

Conclusions:

  • Neonatal vaccination is crucial for preventing life-threatening infections in infants.
  • Existing vaccines show promise, but further advancements are needed for optimal protection.
  • Novel approaches are being investigated to improve the immunogenicity and effectiveness of vaccines in neonates.